We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.9B
AUM Growth
+$433M
Cap. Flow
+$143M
Cap. Flow %
1.31%
Top 10 Hldgs %
18.12%
Holding
2,433
New
160
Increased
1,129
Reduced
851
Closed
234
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALE
1601
DELISTED
Allete
ALE
$384K ﹤0.01%
4,617
+341
+8% +$28.1K
SVC
1602
Service Properties Trust
SVC
$1.08B
$384K ﹤0.01%
3,071
+736
+32% +$94.4K
MAS icon
1603
Masco
MAS
$14.9B
$381K ﹤0.01%
9,713
-3,718
-28% -$143K
TAL icon
1604
TAL Education Group
TAL
$6.63B
$381K ﹤0.01%
10,000
-990
-9% -$35.8K
IRBT
1605
DELISTED
iRobot
IRBT
$380K ﹤0.01%
4,152
+779
+23% +$79K
LAND
1606
Gladstone Land Corp
LAND
$352M
$380K ﹤0.01%
32,957
-1,773
-5% -$21.9K
MUNI icon
1607
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
$380K ﹤0.01%
6,919
+1,188
+21% +$64.5K
VMO icon
1608
Invesco Municipal Opportunity Trust
VMO
$664M
$380K ﹤0.01%
30,901
+270
+0.9% +$3.25K
APH icon
1609
Amphenol
APH
$208B
$379K ﹤0.01%
15,812
+1,412
+10% +$34K
WAT icon
1610
Waters Corp
WAT
$40.5B
$379K ﹤0.01%
1,763
+121
+7% +$26.4K
FFC
1611
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$786M
$376K ﹤0.01%
18,841
-5,000
-21% -$97.6K
NNY icon
1612
Nuveen New York Municipal Value Fund
NNY
$157M
$376K ﹤0.01%
37,701
+462
+1% +$4.6K
NTES icon
1613
NetEase
NTES
$79.2B
$376K ﹤0.01%
7,345
-625
-8% -$33.2K
BBY icon
1614
Best Buy
BBY
$17.5B
$375K ﹤0.01%
5,379
+383
+8% +$26.7K
BNO icon
1615
United States Brent Oil Fund
BNO
$784M
$374K ﹤0.01%
19,725
+1,769
+10% +$34.7K
FXE icon
1616
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$374K ﹤0.01%
+3,455
New +$370K
EQR icon
1617
Equity Residential
EQR
$24.3B
$373K ﹤0.01%
4,913
+25
+0.5% +$1.91K
SAGE
1618
DELISTED
Sage Therapeutics
SAGE
$373K ﹤0.01%
+2,035
New +$347K
MOO icon
1619
VanEck Agribusiness ETF
MOO
$973M
$371K ﹤0.01%
5,558
-8,009
-59% -$508K
SYF icon
1620
Synchrony
SYF
$25.4B
$371K ﹤0.01%
10,697
+63
+0.6% +$2.13K
CHK
1621
DELISTED
Chesapeake Energy Corporation
CHK
$371K ﹤0.01%
952
+134
+16% +$67K
ACGL icon
1622
Arch Capital
ACGL
$33.6B
$367K ﹤0.01%
9,908
+700
+8% +$23.9K
CF icon
1623
CF Industries
CF
$17.5B
$367K ﹤0.01%
7,854
-709
-8% -$30.8K
CDK
1624
DELISTED
CDK Global, Inc.
CDK
$367K ﹤0.01%
7,416
+1,400
+23% +$75K
EBTC
1625
DELISTED
Enterprise Bancorp
EBTC
$365K ﹤0.01%
11,503
+2
+0% +$60

Similar funds

Cambridge Investment Research Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Cambridge Investment Research Advisors held 2,433 positions worth $10.9B, up 4.1% from $10.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2019 filing shows 160 new, 1,129 increased, 851 reduced and 234 closed positions. Its largest new stake was WisdomTree International ESG Fund: 441,613 shares worth $10.6M. The largest sale was Vanguard S&P 500 ETF, an estimated $38M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2019 buy was WisdomTree International ESG Fund: 441,613 shares worth $10.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q2 2019, an estimated $27M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $38M.
  • Cambridge Investment Research Advisors fully exited DuPont de Nemours in Q2 2019, selling an estimated $17.5M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $10.9B portfolio in Q2 2019.
  • Cambridge Investment Research Advisors opened 160 new positions and closed 234 in Q2 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $10.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2019, filed 15 Aug 2019.